Original paper
Vitamin-B12-Conjugated Sericin Micelles for Targeting Gastric Cancer and Reversing Drug Resistance
Abstract
Although paclitaxel (PTX) is a promising front-line agent for gastric cancer (GC), its hydrophobic characteristics and ineffective cancer site access have limited its clinical applications. Previously, we have introduced nanosized drug delivery systems based on sericin micelles, to reverse drug resistance. However, these micelles lacked the ability to selectively bind and directly affect cancer cells. In general, vitamin B12 (VB12) is highly...
Paper Details
Title
Vitamin-B12-Conjugated Sericin Micelles for Targeting Gastric Cancer and Reversing Drug Resistance
Published Date
Jan 1, 2018
Journal
Citation AnalysisPro
You’ll need to upgrade your plan to Pro
Looking to understand the true influence of a researcher’s work across journals & affiliations?
- Scinapse’s Top 10 Citation Journals & Affiliations graph reveals the quality and authenticity of citations received by a paper.
- Discover whether citations have been inflated due to self-citations, or if citations include institutional bias.
Notes
History